Rchr
J-GLOBAL ID:200901086819546622   Update date: Jun. 09, 2020

Sasaki Akira

ササキ アキラ | Sasaki Akira
Affiliation and department:
Job title: Professor
Homepage URL  (2): http://www.dent.okayama-u.ac.jp/2kouge/index-sc-j.htmlhttp://www.dent.okayama-u.ac.jp/2kouge/index-sc-j.html
Research field  (1): Surgical dentistry
Research keywords  (1): Oral and Maxillofacial Surgery
Papers (77):
  • Kenichi Matsumoto, Tsuyoshi Shimo, Naito Kurio, Tatsuo Okui, Soichiro Ibaragi, Yuki Kunisada, Kyoichi Obata, Masanori Masui, Pang Pai, Yuu Horikiri, Nobuyuki Yamanaka, Masaharu Takigawa, Akira Sasaki. Low-intensity pulsed ultrasound stimulation promotes osteoblast differentiation through hedgehog signaling. Journal of cellular biochemistry. 2018. 119. 6. 4352-4360
  • Shinya Sento, Naoya Kitamura, Tetsuya Yamamoto, Koichi Nakashiro, Hiroyuki Hamakawa, Soichiro Ibaragi, Akira Sasaki, Natsumi Takamaru, Yoji Miyamoto, Isamu Kodani, Kazuo Ryoke, Katsuaki Mishima, Yoshiya Ueyama. Palonosetron Prevents Highly Emetogenic Chemotherapy-induced Nausea and Vomiting in Oral Cancer Patients. ANTICANCER RESEARCH. 2017. 37. 12. 6977-6981
  • Hiromasa Kuroda, Naito Kurio, Tsuyoshi Shimo, Kenichi Matsumoto, Masanori Masui, Kiyofumi Takabatake, Tatsuo Okui, Soichiro Ibaragi, Yuki Kunisada, Kyoichi Obata, Norie Yoshioka, Koji Kishimoto, Hitoshi Nagatsuka, Akira Sasaki. Oral Squamous Cell Carcinoma-derived Sonic Hedgehog Promotes Angiogenesis. ANTICANCER RESEARCH. 2017. 37. 12. 6731-6737
  • Kyoichi Obata, Tsuyoshi Shimo, Tatsuo Okui, Kenichi Matsumoto, Hiroyuki Takada, Kiyofumi Takabatake, Yuki Kunisada, Soichiro Ibaragi, Norie Yoshioka, Koji Kishimoto, Hitoshi Nagatsuka, Akira Sasaki. Role of Neurokinin 3 Receptor Signaling in Oral Squamous Cell Carcinoma. ANTICANCER RESEARCH. 2017. 37. 11. 6119-6123
  • Yuki Kunisada, Shingo Eikawa, Nahoko Tomonobu, Shohei Domae, Takenori Uehara, Shohei Hori, Yukihiro Furusawa, Koji Hase, Akira Sasaki, Heiichiro Udono. Attenuation of CD4(+) CD25(+) Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug. EBIOMEDICINE. 2017. 25. 154-164
more...
MISC (28):
  • Pulmonary fibrosis due to peplomycin therapy for mand bular gingival. Journal of Okayama Dental Society. 10. 2. 255-263
  • A Clinico-statistical study of maxillofacial fractures for five years in our department. Jpn J. Oral & maxillofacial Surgery. 38. 1. 268-276
  • Effects of Matrix Metalloproteinase Inhibitor on Experimental Tongue Carcinoma in Nude Mice(口腔発表). 81th American Association of Oral and maxillofacial Surgery Annual Meeting, Scientific Sessions and Exhibition in conjunction with the British Association of Oral and Maxillofacial Surgeons
  • Experimental Transplantation with Block Bone Grafts Incubated in Bisphosphonate(口腔発表). 81th American Association of Oral and maxillofacial Surgery Annual Meeting, Scientific Sessions and Exhibition in conjunction with the British Association of Oral and Maxillofacial Surgeons
  • in vivo Effects Of Bisposphonate Treatment On Particulate Cancellous Bone marrow(口腔発表). 81th American Association of Oral and maxillofacial Surgery Annual Meeting, Scientific Sessions and Exhibition in conjunction with the British Association of Oral and Maxillofacial Surgeons
more...
Books (2):
  • Oral Cancer
    InTech 2012
  • Squamous Cell Carcinoma
    InTech 2012
Lectures and oral presentations  (5):
  • Identification of GKAP1 as a novel cancer antigen and its immunogenicity in oral squamous cell carcinoma.
    (21th Congress of the European Association for Cranio-Maxillo-Facial Surgery 2012)
  • Expressin of cytokeration in development, invasion and metastasis of oral squamous cell carcinoma.
    (21th Congress of the European Association for Cranio-Maxillo-Facial Surgery 2012)
  • Neamine inhibits progression of oral cancer by suppressing angiogenin-stimulated angiogenesis and cancer cell proliferation.
    (21th Congress of the European Association for Cranio-Maxillo-Facial Surgery 2012)
  • Novel HSP90 Inhibitor NVP-AUY922 enhances anti-tumor effect of temsirolimus against oral squamous cell carcinoma.
    (The 5th International Symposium for Future Technology Creating Better Human Health and Society 2012)
  • Anti-tumor effect of a novel FAK inhibitor TAE226 against human oral squamous cell carcinoma.
    (The 5th International Symposium for Future Technology Creating Better Human Health and Society 2012)
Professional career (1):
  • PhD (Okayama University)
Work history (11):
  • 2018 - 現在 Health Sciences University of Hokkaido
  • 2016 - 現在 The University of Tokushima
  • 2008 - 現在 Hiroshima University
  • 2012 - 2017 Yamaguchi University
  • 2011 - 2016 Osaka University
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page